Migraines and Selective Serotonin Reuptake Inhibitors
Links shared publicly online about this topic
Ssris (Selective Serotonin Reuptake Inhibitors) - NHS Choices
healthcare.tweetmeme.com — “All the news on healthcare” View full resource at healthcare.tweetmeme.com
Most Recently Shared on January 2, 2011 at 4:41 am By:
Healthcare TweetMeme Health Social Media
Ssris (Selective Serotonin Reuptake Inhibitors) - NHS Choices http://retwt.me/1Qp56 (via @AegiSite)
Selective serotonin-reuptake inhibitors and recovery after stroke : The Lancet Neurology
thelancet.com — “Selective serotonin-reuptake inhibitors and recovery after stroke. By - Robert G Robinson, Harold P Adams” View full resource at thelancet.com
Most Recently Shared on January 21, 2011 at 12:03 am By:
[Comment] Selective serotonin-reuptake inhibitors and recovery after stroke: Motor impairments are an important ... http://bit.ly/ibew9T
Toxicity, Selective Serotonin Reuptake Inhibitor: eMedicine Emergency Medicine
emedicine.medscape.com — “Overview: Selective serotonin reuptake inhibitors (SSRIs) are widely prescribed medications for the treatment of depression, obsessive-compulsive disorder, bulimia, anorexia nervosa, panic disorder, and social phobia. The majority of all antidepressants prescribed in the United States are from ...” View full resource at emedicine.medscape.com
Most Recently Shared on May 4, 2010 at 2:02 am By:
Susan Scroggins Active Health Library and Health Advocate
SSRIs are sometimes prescribed to treat depression & other social disorders. They can be toxic. Learn signs & symptoms. http://bit.ly/97YIyY
Selective Serotonin Reuptake Inhibitor Treatment and Depression Are Associated with Poststroke Mortality (July/August)
theannals.com — “Selective Serotonin Reuptake Inhibitor Treatment and Depression Are Associated with Poststroke Mortality (July/August)” View full resource at theannals.com
Most Recently Shared on July 13, 2011 at 6:07 am By:
Selective Serotonin Reuptake Inhibitor Treatment and Depression Are Associated with Poststroke Mortality (July... http://bit.ly/qvC8fq
Selective Serotonin Reuptake Inhibitor Use During Pregnancy May Increase Risk of Autism Spectrum Disorders | ThirdAge
thirdage.com — “Selective serotonin reuptake inhibitor use during pregnancy may increase a child's risk of autism spectrum disorders.” View full resource at thirdage.com
Most Recently Shared on July 4, 2011 at 11:55 pm By:
Selective Serotonin Reuptake Inhibitor Use During Pregnancy May Increase Risk of Autism Spectrum Disorders http://bit.ly/myd6lp
Antidepressants: Selective Serotonin And Norepinephrine Reuptake Inhibitor Drugs Show Benefits In German Study
feeds.sciencedaily.com — “Patients with depression benefit from taking venlafaxine and duloxetine, two drugs belonging to the selective serotonin and norepinephrine reuptake inhibitor drug class. This is the conclusion of a report published by German researchers. Clinical comparisons with a sham drug (placebo) show that patients respond better to the therapy, suffering less from the symptoms of depression.” View full resource at feeds.sciencedaily.com
Most Recently Shared on August 28, 2009 at 1:16 pm By:
Antidepressants: Selective Serotonin And Norepinephrine Reuptake Inhibitor Drugs Show Benefits In German Study: .. http://bit.ly/SbO3V
Diminished Neural Processing of Aversive and Rewarding Stimuli During Selective Serotonin Reuptake Inhibitor Treatment
journals.elsevierhealth.com — “Biological Psychiatry, Volume 67, Issue 5, Pages 439-445, 1 March 2010, Authors:Ciara McCabe; Zevic Mishor; Philip J. Cowen; Catherine J. Harmer” View full resource at journals.elsevierhealth.com
Most Recently Shared on February 12, 2010 at 2:56 pm By:
William Yates, M.D. Psychiatrist, Family Medicine Doctor, Physician, and Doctor
SSRI antidepressants may dampen brain reward response as well as response to adverse stimuli. http://ow.ly/16JG6
Economic Impact of Therapeutic Substitution of a Brand Selective Serotonin Reuptake Inhibitor with an Alternative Generic Selective Serotonin Reuptake Inhibitor in Patients with Major Depressive Disorder (April) -- Wu et al., 10.1345/aph.1P482 -- The Anna
theannals.com — “Economic Impact of Therapeutic Substitution of a Brand Selective Serotonin Reuptake Inhibitor with an Alternative Generic Selective Serotonin Reuptake Inhibitor in Patients with Major Depressive Disorder (April) -- Wu et al., 10.1345/aph.1P482 -- The Annals of Pharmacotherapy” View full resource at theannals.com
Most Recently Shared on March 18, 2011 at 2:57 am By:
Economic Impact of Therapeutic Substitution of a Brand Selective Serotonin Reuptake Inhibitor with an Alternativ... http://bit.ly/fhSCip
Selective Serotonin Reuptake Inhibitor (SSRI) Antidepressants: Drug Safety Communication - Use During Pregnancy and Potential Risk of Persistent Pulmonary Hypertension of the Newborn
fda.gov — “Conflicting results from different studies makes it premature to reach any conclusion about a possible link between SSRI use in pregnancy and PPHN.” View full resource at fda.gov
Most Recently Shared on December 15, 2011 at 2:00 pm By:
Selective serotonin reuptake inhibitor exposure during early pregnancy and the risk of birth defects - Gentile - 2011 - Acta Psychiatrica Scandinavica - Wiley Online Library
onlinelibrary.wiley.com — “Selective serotonin reuptake inhibitor exposure during early pregnancy and the risk of birth defects - Gentile - 2011 - Acta Psychiatrica Scandinavica - Wiley Online Library” View full resource at onlinelibrary.wiley.com
Most Recently Shared on January 26, 2011 at 12:28 pm By:
Selective serotonin reuptake inhibitor exposure during early pregnancy and the risk of birth defects: Conclusion... http://bit.ly/eIErcZ
Psychiatry Medical News about Serotonin Syndrome Serotonin Uptake Inhibitors Tryptamines
mdlinx.com — “The FDA Alert on Serotonin Syndrome With Use of Triptans Combined With Selective Serotonin Reuptake Inhibitors or Selective Serotonin-Norepinephrine Reuptake Inhibitors: American Headache Society Position Paper” View full resource at mdlinx.com
Most Recently Shared on June 12, 2010 at 12:55 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
The FDA Alert on Serotonin Syndrome With Use of Triptans Combined With Selective Serotonin Reuptake Inhi... http://tinyurl.com/34dz7da #PSY
The effect of selective serotonin re-uptake inhibitors on the risk of myocardial infarction in a cohort of patients with depression - Kimmel - 2011 - British Journal of Clinical Pharmacology - Wiley Online Library
onlinelibrary.wiley.com — “The effect of selective serotonin re-uptake inhibitors on the risk of myocardial infarction in a cohort of patients with depression - Kimmel - 2011 - British Journal of Clinical Pharmacology - Wiley Online Library” View full resource at onlinelibrary.wiley.com
Most Recently Shared on August 10, 2011 at 11:09 pm By:
Depression Wisdom Active Health Library and OW Health
The effect of selective serotonin reâ€uptake inhibitors on the risk of myocardial infarction in a cohort of pat... http://bit.ly/pEOQ2Q
Neurology Medical News about Serotonin Syndrome Serotonin Uptake Inhibitors Tryptamines
mdlinx.com — “The FDA Alert on Serotonin Syndrome With Use of Triptans Combined With Selective Serotonin Reuptake Inhibitors or Selective Serotonin-Norepinephrine Reuptake Inhibitors: American Headache Society Position Paper” View full resource at mdlinx.com
Most Recently Shared on June 11, 2010 at 11:26 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
The FDA Alert on Serotonin Syndrome With Use of Triptans Combined With Selective Serotonin Reupt... http://bit.ly/9gXG1u #neurology #mdlinx
Emergency Med Medical News about Serotonin Syndrome Serotonin Uptake Inhibitors Tryptamines
mdlinx.com — “The FDA Alert on Serotonin Syndrome With Use of Triptans Combined With Selective Serotonin Reuptake Inhibitors or Selective Serotonin-Norepinephrine Reuptake Inhibitors: American Headache Society Position Paper” View full resource at mdlinx.com
Most Recently Shared on June 10, 2010 at 1:27 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
The FDA Alert on Serotonin Syndrome With Use of Triptans Combined With Selective Serotonin Reuptake Inh... http://bit.ly/am4Le9 #ER #mdlinx
Annals of General Psychiatry | Full text | Adding 5-hydroxytryptamine receptor type 3 antagonists may reduce drug-induced nausea in poor insight obsessive-compulsive patients taking off-label doses of selective serotonin reuptake inhibitors: a 52-week fol
annals-general-psychiatry.com — “Annals of General Psychiatry | Full text | Adding 5-hydroxytryptamine receptor type 3 antagonists may reduce drug-induced nausea in poor insight obsessive-compulsive patients taking off-label doses of selective serotonin reuptake inhibitors: a 52-week follow-up case report” View full resource at annals-general-psychiatry.com
Most Recently Shared on January 28, 2011 at 6:56 pm By:
Ask a Psychiatrist Psychiatrist, Physician, and Doctor
5-HT3 antagonists in obsessive-compulsive disorder http://bit.ly/eX7zhl
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
Healthcare TweetMeme
Tracking Twitter Healthcare Memes from TweetMeme
-
Stroke OW
Organizing stroke and mini-stroke resources shared by health experts, advocates, and organizations into WisdomCards.
-
Susan Scroggins
Passionate about sharing quality health resources for good health. Content curator and organizer at organizedwisdom.com.
Advertisement
